Advanced Medical Solutions Grp PLC Director/PDMR Shareholding (6058H)
June 09 2017 - 02:00AM
UK Regulatory
TIDMAMS
RNS Number : 6058H
Advanced Medical Solutions Grp PLC
08 June 2017
9 June 2017
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR and PCA Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a
leading developer and manufacturer of advanced products for the
global surgical and wound care markets, announces that it was
notified on 5 June 2017 that Angela Coates, the wife of Simon
Coates who is a Senior Manager and PDMR, had sold 6,000 Ordinary
Shares of 5p held in her name on 5 June 2017.
Following these transactions the beneficial ownership of Simon
Coates is as follows:
PDMR Holding Number Sale Resultant % of issued
prior of shares price holding share
to sale sold (p) capital
-------------- --------- ----------- -------- ---------- ------------
Simon Coates 79,481 6,000 287.25p 73,481 0.35%
-------------- --------- ----------- -------- ---------- ------------
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------------
a) Name: Angela Coates (the wife of Simon
Coates)
--- ---------------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status: PCA of a Senior Manager/PDMR
--- ---------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------------
b) Nature of the transaction:
* Sale of 6,000 Ordinary Shares of 5p from shares held
by Angela Coates in her own name
--- ---------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
----------- ----------
GBP2.8725 6,000
----------- ----------
--- ---------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: 6,000
Aggregated price: GBP2.8725
--- ---------------------------------------------------------------
e) Date of the transaction: 05/06/2017
--- ---------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------------
- End -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Chief Financial
Officer
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Jonathan AMS@consilium-comms.com
Birt / Matthew Neal / Hendrik
Thys
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Daniel Adams / Patrick Robb
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical and wound care markets, focused on quality outcomes for
patients and value for payors. AMS has a wide range of wound care
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it sells under white label
as well as its own brand ActivHeal(R) , and surgical tissue
adhesives, sutures and haemostats, which markets under its own
brands; LiquiBand(R) and RESORBA(R) ..
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 70 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Company has 600 employees. For more
information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDBGDLDBGBGRI
(END) Dow Jones Newswires
June 09, 2017 02:00 ET (06:00 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2023 to Mar 2024